US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Lisinopril and Hydrochlorothiazide Tablets USP

Reason Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle.

Lupin Pharmaceuticals Inc. NDC 68180-519-02 D-1581-2019
Class II · Moderate risk Terminated

Monsel's

Reason Microbial Contamination of Non-Sterile Products and Superpotent Drug: FDA analysis revealed microbial contamination in addition to high out of specification results for iron content.

Dercher Enterprises, Inc., DBA Gordon Laboratories NDC 10481-0112-8 D-1528-2019
Class II · Moderate risk Terminated

Keppra

Reason Failed Dissolution Specifications.

Ucb, Inc NDC 50474-597-66 D-1838-2019
Class III · Low risk Terminated

Methylergonovine Maleate USP 0.2 mg Tablets a) 12 count

Reason Presence of Foreign Tablet/Capsule; one Promethazine tablet was found in a bottle of Methylergonovine Maleate tablets

Amneal Pharmaceuticals, Inc. NDC 69238-1605-02 D-1516-2019
Class II · Moderate risk Terminated

0.9% Sodium Chloride Injection USP

Reason Lack of Assurance of Sterility: Bags have potential to leak.

Baxter Healthcare Corporation NDC 0338-0049-38 D-1514-2019
Class II · Moderate risk Terminated

Neomycin Sulfate 3.5 mg/Polymyxin B Sulfate 10

Reason CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.

Preferred Pharmaceuticals, Inc NDC 68788-9373-03 D-1491-2019
Class II · Moderate risk Terminated

Tamsulosin Hydrochloride Capsules

Reason Failed Dissolution Specifications

Macleods Pharma Usa Inc NDC 33342-159-11 D-1844-2019
Class II · Moderate risk Terminated

Lisinopril and Hydrochlorothiazide Tablets USP

Reason Presence of Foreign Substance; Product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles.

Lupin Pharmaceuticals Inc. NDC 68180-518-01 D-1720-2019
Class II · Moderate risk Terminated

Timolol-Latanoprost P-F

Reason Subpotent Drug

ImprimisRx NJ D-1578-2019
Class III · Low risk Terminated

Nystatin and Triamcinolone Acetonide Cream USP100

Reason Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation.

Lupin Pharmaceuticals Inc. NDC 68180-545-01 D-1518-2019
Class II · Moderate risk Terminated

Clobazam Oral Suspension

Reason Microbial Contamination of Non-Sterile Products: Out-of-specification results for Microbial Enumeration Tests USP <61> was observed.

Bionpharma Inc. NDC 69452-116-45 D-1519-2019
Class II · Moderate risk Terminated

Temozolomide Capsules

Reason CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Deva Holding AS - Cerkezkoy Subesi NDC 67877-542-07 D-1513-2019
Class II · Moderate risk Terminated

Temozolomide Capsules

Reason CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Deva Holding AS - Cerkezkoy Subesi NDC 67877-541-07 D-1512-2019
Class II · Moderate risk Terminated

Temozolomide Capsules

Reason CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Deva Holding AS - Cerkezkoy Subesi NDC 67877-540-07 D-1511-2019
Class II · Moderate risk Terminated

Temozolomide Capsules

Reason CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Deva Holding AS - Cerkezkoy Subesi NDC 67877-539-07 D-1510-2019
Class II · Moderate risk Terminated

Temozolomide Capsules

Reason CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Deva Holding AS - Cerkezkoy Subesi NDC 67877-538-07 D-1509-2019
Class II · Moderate risk Terminated

Temozolomide Capsules

Reason CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Deva Holding AS - Cerkezkoy Subesi NDC 67877-537-07 D-1508-2019
Class II · Moderate risk Terminated

CVS Health Children's Allergy Relief Liquid Medication…

Reason CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

Unipharma, Llc. NDC 69842-261-01 D-1631-2019
Class II · Moderate risk Terminated

LA FRESH travel lite Sunnyside Lotion Wipe silky

Reason Marketed without an Approved NDA/ANDA: The product may be construed a sunscreen due to labeling of the product and comments about the product found on e-commerce websites.

La Fresh Group, Inc. D-1566-2019
Class II · Moderate risk Terminated

Fungo Off Capsules

Reason CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.

Herbal Doctor Remedies D-1629-2019
Class II · Moderate risk Terminated

Asma Stopper Capsules

Reason CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.

Herbal Doctor Remedies D-1628-2019